1. Dendritic cell based vaccination strategy: an evolving paradigm

   • Anna C. Filley
   • Mahua Dey

   Topic Review 22 April 2017 Pages: 223 - 235

   

2. Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence

   • Ellen M. P. van Coevorden-van Loon
   • Marijke B. Coomans
   • Martin J. van den Bent

   Topic Review Open access 24 May 2017 Pages: 237 - 246

   

3. MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation

   • Chen Jin
   • Minhong Li
   • Yugang Jiang

   Laboratory Investigation 15 May 2017 Pages: 247 - 255

   

4. Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy

   • Ilya V. Ulasov
   • Haidn Foster
   • Charles Cobbs

   Laboratory Investigation 22 April 2017 Pages: 257 - 264

   

5. Is mortality due to primary malignant brain and other central nervous system tumors decreasing?

   • Haley Gittleman
   • Courtney Kromer
   • Jill S. Barnholtz-Sloan

   Laboratory Investigation 03 May 2017 Pages: 265 - 275

   

6. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome

   • Tsubasa Miyazaki
   • Eiichi Ishikawa
   • Akira Matsumura

   Laboratory Investigation 26 April 2017 Pages: 277 - 285

   

7. SPECT imaging and radionuclide therapy of glioma using ¹³¹I labeled Buthus martensii Karsch chlorotoxin

   • Wenli Qiao
   • Lingzhou Zhao
   • Jinhua Zhao

   Laboratory Investigation 09 May 2017 Pages: 287 - 295

   

8. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells

   • Ryogo Kikuchi
   • Oltea Sampetrean
   • Masahiro Toda

   Laboratory Investigation 29 May 2017 Pages: 297 - 307

   

9. Impact of treatment on survival of patients with secondary glioblastoma

   • Christina Hamisch
   • Maximilian Ruge
   • Stefan J. Grau

   Clinical Study 30 May 2017 Pages: 309 - 313

   

10. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study

    • Caroline Houillier
    • Hervé Ghesquières
    • Khê Hoang-Xuan

    Clinical Study 21 April 2017 Pages: 315 - 320

    

11. Atypical and anaplastic meningioma: outcomes in a population based study

    • T. Garzon-Muvdi
    • W. Yang
    • J. Huang

    Clinical Study 20 April 2017 Pages: 321 - 330

    

12. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases

    • Kamran A. Ahmed
    • Sungjune Kim
    • Bradford A. Perez

    Clinical Study 02 May 2017 Pages: 331 - 338

    

13. Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience

    • Ryan S. Youland
    • David A. Schomas
    • Nadia N. I. Laack

    Clinical Study 21 April 2017 Pages: 339 - 346

    

14. Clinical features and long-term outcomes of pediatric spinal meningiomas

    • Liang Wu
    • Chenlong Yang
    • Yulun Xu

    Clinical Study 21 April 2017 Pages: 347 - 355

    

15. The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies

    • Joseph M. Kim
    • Jacob A. Miller
    • Samuel T. Chao

    Clinical Study 22 April 2017 Pages: 357 - 368

    

16. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma

    • Waqar Haque
    • Vivek Verma
    • Bin S. Teh

    Clinical Study 21 April 2017 Pages: 369 - 375

    

17. Key rates for the grades and transformation ability of glioma: model simulations and clinical cases

    • Elizabeth Scribner
    • James R. Hackney
    • Hassan M. Fathallah-Shaykh

    Clinical Study 27 April 2017 Pages: 377 - 388

    

18. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium

    • Hirohito Yano
    • Noriyuki Nakayama
    • Toru Iwama

    Clinical Study 21 April 2017 Pages: 389 - 397

    

19. Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas

    • Florian Gessler
    • Peter Baumgarten
    • Lutz Weise

    Clinical Study 15 May 2017 Pages: 399 - 407

    

20. Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system

    • Connor J. Kinslow
    • Raj S. Rajpara
    • Tony J. C. Wang

    Clinical Study 26 April 2017 Pages: 409 - 417

    

21. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe

    • Emilie Le Rhun
    • Roberta Rudà
    • Michael Weller

    Clinical Study 28 April 2017 Pages: 419 - 427

    

22. Chemoradiation impairs normal developmental cortical thinning in medulloblastoma

    • Palak Kundu
    • Matthew D. Li
    • Iris C. Gibbs

    Clinical Study 22 May 2017 Pages: 429 - 434

    

23. A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases

    • Kyle Arneson
    • Joshua Mondschein
    • Fen Xia

    Clinical Study 09 May 2017 Pages: 435 - 442

    

24. A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

    • Stéphane Goutagny
    • Marco Giovannini
    • Michel Kalamarides

    Letter to the Editor 22 April 2017 Pages: 443 - 445